nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—OPRM1—epilepsy syndrome	0.211	0.638	CbGaD
Alfentanil—ALB—epilepsy syndrome	0.0611	0.185	CbGaD
Alfentanil—ABCB1—epilepsy syndrome	0.0583	0.177	CbGaD
Alfentanil—ALB—Oxcarbazepine—epilepsy syndrome	0.0234	0.0497	CbGbCtD
Alfentanil—ALB—Fosphenytoin—epilepsy syndrome	0.0205	0.0434	CbGbCtD
Alfentanil—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0188	0.0399	CbGbCtD
Alfentanil—ALB—Clonazepam—epilepsy syndrome	0.0185	0.0393	CbGbCtD
Alfentanil—CYP3A7—Carbamazepine—epilepsy syndrome	0.0158	0.0334	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.0158	0.0334	CbGbCtD
Alfentanil—ALB—Rufinamide—epilepsy syndrome	0.0151	0.032	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.0141	0.03	CbGbCtD
Alfentanil—CYP3A7—Phenytoin—epilepsy syndrome	0.0141	0.03	CbGbCtD
Alfentanil—ABCB1—Levetiracetam—epilepsy syndrome	0.0134	0.0284	CbGbCtD
Alfentanil—ALB—Phenytoin—epilepsy syndrome	0.0132	0.028	CbGbCtD
Alfentanil—CYP3A7—Phenobarbital—epilepsy syndrome	0.0126	0.0267	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.0126	0.0267	CbGbCtD
Alfentanil—CYP3A7—Midazolam—epilepsy syndrome	0.0124	0.0263	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.0124	0.0263	CbGbCtD
Alfentanil—ALB—Propofol—epilepsy syndrome	0.0123	0.0261	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.012	0.0253	CbGbCtD
Alfentanil—CYP3A7—Diazepam—epilepsy syndrome	0.012	0.0253	CbGbCtD
Alfentanil—CYP3A5—Carbamazepine—epilepsy syndrome	0.0118	0.0251	CbGbCtD
Alfentanil—ALB—Diazepam—epilepsy syndrome	0.0112	0.0236	CbGbCtD
Alfentanil—CYP3A5—Phenytoin—epilepsy syndrome	0.0106	0.0225	CbGbCtD
Alfentanil—CYP3A5—Phenobarbital—epilepsy syndrome	0.00946	0.02	CbGbCtD
Alfentanil—CYP3A5—Midazolam—epilepsy syndrome	0.00933	0.0198	CbGbCtD
Alfentanil—ABCB1—Clobazam—epilepsy syndrome	0.00929	0.0197	CbGbCtD
Alfentanil—CYP3A5—Diazepam—epilepsy syndrome	0.00897	0.019	CbGbCtD
Alfentanil—ABCB1—Lamotrigine—epilepsy syndrome	0.00895	0.019	CbGbCtD
Alfentanil—ABCB1—Carbamazepine—epilepsy syndrome	0.0077	0.0163	CbGbCtD
Alfentanil—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00735	0.0156	CbGbCtD
Alfentanil—CYP3A5—Valproic Acid—epilepsy syndrome	0.00707	0.015	CbGbCtD
Alfentanil—ABCB1—Phenytoin—epilepsy syndrome	0.00691	0.0146	CbGbCtD
Alfentanil—CYP3A4—Felbamate—epilepsy syndrome	0.00683	0.0145	CbGbCtD
Alfentanil—CYP3A4—Trimethadione—epilepsy syndrome	0.00683	0.0145	CbGbCtD
Alfentanil—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00642	0.0136	CbGbCtD
Alfentanil—ABCB1—Phenobarbital—epilepsy syndrome	0.00616	0.013	CbGbCtD
Alfentanil—ABCB1—Midazolam—epilepsy syndrome	0.00607	0.0129	CbGbCtD
Alfentanil—ABCB1—Diazepam—epilepsy syndrome	0.00584	0.0124	CbGbCtD
Alfentanil—CYP3A4—Clonazepam—epilepsy syndrome	0.00581	0.0123	CbGbCtD
Alfentanil—CYP3A4—Clobazam—epilepsy syndrome	0.00557	0.0118	CbGbCtD
Alfentanil—CYP3A4—Rufinamide—epilepsy syndrome	0.00473	0.01	CbGbCtD
Alfentanil—CYP3A4—Carbamazepine—epilepsy syndrome	0.00461	0.00977	CbGbCtD
Alfentanil—CYP3A4—Primidone—epilepsy syndrome	0.00431	0.00912	CbGbCtD
Alfentanil—CYP3A4—Phenytoin—epilepsy syndrome	0.00414	0.00877	CbGbCtD
Alfentanil—CYP3A4—Propofol—epilepsy syndrome	0.00386	0.00818	CbGbCtD
Alfentanil—CYP3A4—Phenobarbital—epilepsy syndrome	0.00369	0.00781	CbGbCtD
Alfentanil—CYP3A4—Acetazolamide—epilepsy syndrome	0.00369	0.00781	CbGbCtD
Alfentanil—CYP3A4—Midazolam—epilepsy syndrome	0.00364	0.0077	CbGbCtD
Alfentanil—CYP3A4—Diazepam—epilepsy syndrome	0.0035	0.00741	CbGbCtD
Alfentanil—CYP3A4—Zonisamide—epilepsy syndrome	0.00341	0.00723	CbGbCtD
Alfentanil—CYP3A4—Valproic Acid—epilepsy syndrome	0.00276	0.00584	CbGbCtD
Alfentanil—CYP3A4—Topiramate—epilepsy syndrome	0.00249	0.00527	CbGbCtD
Alfentanil—Remifentanil—OPRD1—epilepsy syndrome	0.00094	0.254	CrCbGaD
Alfentanil—Sufentanil—OPRD1—epilepsy syndrome	0.000838	0.226	CrCbGaD
Alfentanil—Remifentanil—OPRM1—epilepsy syndrome	0.000719	0.194	CrCbGaD
Alfentanil—Sufentanil—OPRM1—epilepsy syndrome	0.000641	0.173	CrCbGaD
Alfentanil—OPRM1—telencephalic ventricle—epilepsy syndrome	0.000564	0.227	CbGeAlD
Alfentanil—OPRM1—ganglion—epilepsy syndrome	0.000351	0.141	CbGeAlD
Alfentanil—Fentanyl—OPRD1—epilepsy syndrome	0.000285	0.077	CrCbGaD
Alfentanil—Fentanyl—OPRM1—epilepsy syndrome	0.000218	0.0589	CrCbGaD
Alfentanil—OPRM1—brainstem—epilepsy syndrome	0.000153	0.0614	CbGeAlD
Alfentanil—OPRM1—forebrain—epilepsy syndrome	0.000147	0.0593	CbGeAlD
Alfentanil—OPRM1—telencephalon—epilepsy syndrome	0.000135	0.0545	CbGeAlD
Alfentanil—OPRM1—midbrain—epilepsy syndrome	9.72e-05	0.0392	CbGeAlD
Alfentanil—OPRM1—spinal cord—epilepsy syndrome	9.48e-05	0.0382	CbGeAlD
Alfentanil—ORM1—spinal cord—epilepsy syndrome	9.26e-05	0.0373	CbGeAlD
Alfentanil—OPRM1—head—epilepsy syndrome	8.43e-05	0.034	CbGeAlD
Alfentanil—Urticaria—Clonazepam—epilepsy syndrome	8.06e-05	0.000528	CcSEcCtD
Alfentanil—Eye disorder—Gabapentin—epilepsy syndrome	8.05e-05	0.000528	CcSEcCtD
Alfentanil—Dizziness—Midazolam—epilepsy syndrome	8.03e-05	0.000527	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	8.02e-05	0.000526	CcSEcCtD
Alfentanil—Body temperature increased—Clonazepam—epilepsy syndrome	8.02e-05	0.000526	CcSEcCtD
Alfentanil—Fatigue—Lamotrigine—epilepsy syndrome	8.01e-05	0.000526	CcSEcCtD
Alfentanil—Urticaria—Phenytoin—epilepsy syndrome	8e-05	0.000525	CcSEcCtD
Alfentanil—Cardiac disorder—Gabapentin—epilepsy syndrome	8e-05	0.000525	CcSEcCtD
Alfentanil—OPRM1—nervous system—epilepsy syndrome	7.99e-05	0.0322	CbGeAlD
Alfentanil—Pruritus—Vigabatrin—epilepsy syndrome	7.98e-05	0.000524	CcSEcCtD
Alfentanil—Asthenia—Diazepam—epilepsy syndrome	7.97e-05	0.000523	CcSEcCtD
Alfentanil—Body temperature increased—Phenytoin—epilepsy syndrome	7.96e-05	0.000522	CcSEcCtD
Alfentanil—Urticaria—Oxcarbazepine—epilepsy syndrome	7.96e-05	0.000522	CcSEcCtD
Alfentanil—Pain—Lamotrigine—epilepsy syndrome	7.95e-05	0.000521	CcSEcCtD
Alfentanil—Nausea—Acetazolamide—epilepsy syndrome	7.94e-05	0.000521	CcSEcCtD
Alfentanil—Dizziness—Levetiracetam—epilepsy syndrome	7.93e-05	0.00052	CcSEcCtD
Alfentanil—Feeling abnormal—Carbamazepine—epilepsy syndrome	7.92e-05	0.00052	CcSEcCtD
Alfentanil—Body temperature increased—Oxcarbazepine—epilepsy syndrome	7.92e-05	0.00052	CcSEcCtD
Alfentanil—Cough—Valproic Acid—epilepsy syndrome	7.89e-05	0.000518	CcSEcCtD
Alfentanil—Vomiting—Propofol—epilepsy syndrome	7.89e-05	0.000518	CcSEcCtD
Alfentanil—Pruritus—Diazepam—epilepsy syndrome	7.86e-05	0.000515	CcSEcCtD
Alfentanil—Rash—Propofol—epilepsy syndrome	7.83e-05	0.000513	CcSEcCtD
Alfentanil—Dermatitis—Propofol—epilepsy syndrome	7.82e-05	0.000513	CcSEcCtD
Alfentanil—Hypertension—Valproic Acid—epilepsy syndrome	7.81e-05	0.000512	CcSEcCtD
Alfentanil—ORM1—nervous system—epilepsy syndrome	7.8e-05	0.0314	CbGeAlD
Alfentanil—Immune system disorder—Gabapentin—epilepsy syndrome	7.78e-05	0.000511	CcSEcCtD
Alfentanil—Headache—Propofol—epilepsy syndrome	7.78e-05	0.00051	CcSEcCtD
Alfentanil—Mediastinal disorder—Gabapentin—epilepsy syndrome	7.76e-05	0.000509	CcSEcCtD
Alfentanil—Hypersensitivity—Zonisamide—epilepsy syndrome	7.75e-05	0.000509	CcSEcCtD
Alfentanil—Chills—Gabapentin—epilepsy syndrome	7.73e-05	0.000507	CcSEcCtD
Alfentanil—Vomiting—Midazolam—epilepsy syndrome	7.72e-05	0.000506	CcSEcCtD
Alfentanil—Asthenia—Felbamate—epilepsy syndrome	7.71e-05	0.000506	CcSEcCtD
Alfentanil—Vision blurred—Pregabalin—epilepsy syndrome	7.71e-05	0.000506	CcSEcCtD
Alfentanil—OPRM1—central nervous system—epilepsy syndrome	7.69e-05	0.031	CbGeAlD
Alfentanil—Feeling abnormal—Lamotrigine—epilepsy syndrome	7.66e-05	0.000502	CcSEcCtD
Alfentanil—Rash—Midazolam—epilepsy syndrome	7.66e-05	0.000502	CcSEcCtD
Alfentanil—Dizziness—Fosphenytoin—epilepsy syndrome	7.65e-05	0.000502	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	7.65e-05	0.000502	CcSEcCtD
Alfentanil—Dermatitis—Midazolam—epilepsy syndrome	7.65e-05	0.000502	CcSEcCtD
Alfentanil—Urticaria—Carbamazepine—epilepsy syndrome	7.64e-05	0.000501	CcSEcCtD
Alfentanil—Vomiting—Levetiracetam—epilepsy syndrome	7.62e-05	0.0005	CcSEcCtD
Alfentanil—Epistaxis—Topiramate—epilepsy syndrome	7.62e-05	0.0005	CcSEcCtD
Alfentanil—Headache—Midazolam—epilepsy syndrome	7.61e-05	0.000499	CcSEcCtD
Alfentanil—Pruritus—Felbamate—epilepsy syndrome	7.6e-05	0.000499	CcSEcCtD
Alfentanil—Body temperature increased—Carbamazepine—epilepsy syndrome	7.6e-05	0.000499	CcSEcCtD
Alfentanil—Rash—Levetiracetam—epilepsy syndrome	7.56e-05	0.000496	CcSEcCtD
Alfentanil—Dermatitis—Levetiracetam—epilepsy syndrome	7.55e-05	0.000496	CcSEcCtD
Alfentanil—Asthenia—Zonisamide—epilepsy syndrome	7.55e-05	0.000495	CcSEcCtD
Alfentanil—Mental disorder—Gabapentin—epilepsy syndrome	7.55e-05	0.000495	CcSEcCtD
Alfentanil—Agitation—Pregabalin—epilepsy syndrome	7.52e-05	0.000493	CcSEcCtD
Alfentanil—Headache—Levetiracetam—epilepsy syndrome	7.51e-05	0.000493	CcSEcCtD
Alfentanil—ORM1—central nervous system—epilepsy syndrome	7.51e-05	0.0302	CbGeAlD
Alfentanil—Erythema—Gabapentin—epilepsy syndrome	7.5e-05	0.000492	CcSEcCtD
Alfentanil—Hypersensitivity—Clonazepam—epilepsy syndrome	7.47e-05	0.00049	CcSEcCtD
Alfentanil—Dizziness—Vigabatrin—epilepsy syndrome	7.46e-05	0.000489	CcSEcCtD
Alfentanil—Confusional state—Valproic Acid—epilepsy syndrome	7.45e-05	0.000488	CcSEcCtD
Alfentanil—Pruritus—Zonisamide—epilepsy syndrome	7.44e-05	0.000488	CcSEcCtD
Alfentanil—Hypersensitivity—Phenytoin—epilepsy syndrome	7.42e-05	0.000487	CcSEcCtD
Alfentanil—Anaphylactic shock—Valproic Acid—epilepsy syndrome	7.38e-05	0.000484	CcSEcCtD
Alfentanil—Urticaria—Lamotrigine—epilepsy syndrome	7.38e-05	0.000484	CcSEcCtD
Alfentanil—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	7.38e-05	0.000484	CcSEcCtD
Alfentanil—Bradycardia—Topiramate—epilepsy syndrome	7.38e-05	0.000484	CcSEcCtD
Alfentanil—Nausea—Propofol—epilepsy syndrome	7.37e-05	0.000484	CcSEcCtD
Alfentanil—Vomiting—Fosphenytoin—epilepsy syndrome	7.36e-05	0.000483	CcSEcCtD
Alfentanil—Body temperature increased—Lamotrigine—epilepsy syndrome	7.35e-05	0.000482	CcSEcCtD
Alfentanil—Dizziness—Diazepam—epilepsy syndrome	7.34e-05	0.000482	CcSEcCtD
Alfentanil—Rash—Fosphenytoin—epilepsy syndrome	7.3e-05	0.000479	CcSEcCtD
Alfentanil—Dermatitis—Fosphenytoin—epilepsy syndrome	7.29e-05	0.000478	CcSEcCtD
Alfentanil—Asthenia—Clonazepam—epilepsy syndrome	7.28e-05	0.000477	CcSEcCtD
Alfentanil—Headache—Fosphenytoin—epilepsy syndrome	7.25e-05	0.000476	CcSEcCtD
Alfentanil—Nervous system disorder—Valproic Acid—epilepsy syndrome	7.24e-05	0.000475	CcSEcCtD
Alfentanil—Asthenia—Phenytoin—epilepsy syndrome	7.23e-05	0.000474	CcSEcCtD
Alfentanil—Nausea—Midazolam—epilepsy syndrome	7.21e-05	0.000473	CcSEcCtD
Alfentanil—Tachycardia—Valproic Acid—epilepsy syndrome	7.21e-05	0.000473	CcSEcCtD
Alfentanil—Loss of consciousness—Pregabalin—epilepsy syndrome	7.19e-05	0.000472	CcSEcCtD
Alfentanil—Asthenia—Oxcarbazepine—epilepsy syndrome	7.19e-05	0.000472	CcSEcCtD
Alfentanil—Pruritus—Clonazepam—epilepsy syndrome	7.17e-05	0.000471	CcSEcCtD
Alfentanil—Vomiting—Vigabatrin—epilepsy syndrome	7.17e-05	0.000471	CcSEcCtD
Alfentanil—Skin disorder—Valproic Acid—epilepsy syndrome	7.17e-05	0.000471	CcSEcCtD
Alfentanil—Hyperhidrosis—Valproic Acid—epilepsy syndrome	7.14e-05	0.000468	CcSEcCtD
Alfentanil—Cough—Pregabalin—epilepsy syndrome	7.14e-05	0.000468	CcSEcCtD
Alfentanil—Pruritus—Phenytoin—epilepsy syndrome	7.13e-05	0.000467	CcSEcCtD
Alfentanil—Connective tissue disorder—Topiramate—epilepsy syndrome	7.12e-05	0.000467	CcSEcCtD
Alfentanil—Nausea—Levetiracetam—epilepsy syndrome	7.12e-05	0.000467	CcSEcCtD
Alfentanil—Rash—Vigabatrin—epilepsy syndrome	7.11e-05	0.000467	CcSEcCtD
Alfentanil—Dizziness—Felbamate—epilepsy syndrome	7.11e-05	0.000466	CcSEcCtD
Alfentanil—Dermatitis—Vigabatrin—epilepsy syndrome	7.11e-05	0.000466	CcSEcCtD
Alfentanil—Pruritus—Oxcarbazepine—epilepsy syndrome	7.09e-05	0.000465	CcSEcCtD
Alfentanil—Convulsion—Pregabalin—epilepsy syndrome	7.09e-05	0.000465	CcSEcCtD
Alfentanil—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.08e-05	0.000465	CcSEcCtD
Alfentanil—Vision blurred—Gabapentin—epilepsy syndrome	7.07e-05	0.000464	CcSEcCtD
Alfentanil—Headache—Vigabatrin—epilepsy syndrome	7.07e-05	0.000464	CcSEcCtD
Alfentanil—Hypertension—Pregabalin—epilepsy syndrome	7.06e-05	0.000463	CcSEcCtD
Alfentanil—Vomiting—Diazepam—epilepsy syndrome	7.06e-05	0.000463	CcSEcCtD
Alfentanil—Rash—Diazepam—epilepsy syndrome	7e-05	0.000459	CcSEcCtD
Alfentanil—Dermatitis—Diazepam—epilepsy syndrome	7e-05	0.000459	CcSEcCtD
Alfentanil—Visual impairment—Topiramate—epilepsy syndrome	6.99e-05	0.000458	CcSEcCtD
Alfentanil—Dizziness—Zonisamide—epilepsy syndrome	6.96e-05	0.000456	CcSEcCtD
Alfentanil—Headache—Diazepam—epilepsy syndrome	6.96e-05	0.000456	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.92e-05	0.000454	CcSEcCtD
Alfentanil—Hypotension—Valproic Acid—epilepsy syndrome	6.9e-05	0.000453	CcSEcCtD
Alfentanil—Asthenia—Carbamazepine—epilepsy syndrome	6.9e-05	0.000453	CcSEcCtD
Alfentanil—Agitation—Gabapentin—epilepsy syndrome	6.89e-05	0.000452	CcSEcCtD
Alfentanil—Nausea—Fosphenytoin—epilepsy syndrome	6.87e-05	0.000451	CcSEcCtD
Alfentanil—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.85e-05	0.000449	CcSEcCtD
Alfentanil—Vomiting—Felbamate—epilepsy syndrome	6.83e-05	0.000448	CcSEcCtD
Alfentanil—Pruritus—Carbamazepine—epilepsy syndrome	6.8e-05	0.000446	CcSEcCtD
Alfentanil—Rash—Felbamate—epilepsy syndrome	6.78e-05	0.000445	CcSEcCtD
Alfentanil—Eye disorder—Topiramate—epilepsy syndrome	6.77e-05	0.000444	CcSEcCtD
Alfentanil—Dermatitis—Felbamate—epilepsy syndrome	6.77e-05	0.000444	CcSEcCtD
Alfentanil—Headache—Felbamate—epilepsy syndrome	6.73e-05	0.000442	CcSEcCtD
Alfentanil—Confusional state—Pregabalin—epilepsy syndrome	6.73e-05	0.000442	CcSEcCtD
Alfentanil—Cardiac disorder—Topiramate—epilepsy syndrome	6.73e-05	0.000441	CcSEcCtD
Alfentanil—Dizziness—Clonazepam—epilepsy syndrome	6.71e-05	0.00044	CcSEcCtD
Alfentanil—Nausea—Vigabatrin—epilepsy syndrome	6.7e-05	0.00044	CcSEcCtD
Alfentanil—Vomiting—Zonisamide—epilepsy syndrome	6.69e-05	0.000439	CcSEcCtD
Alfentanil—Anaphylactic shock—Pregabalin—epilepsy syndrome	6.68e-05	0.000438	CcSEcCtD
Alfentanil—Asthenia—Lamotrigine—epilepsy syndrome	6.67e-05	0.000437	CcSEcCtD
Alfentanil—Dizziness—Phenytoin—epilepsy syndrome	6.66e-05	0.000437	CcSEcCtD
Alfentanil—Rash—Zonisamide—epilepsy syndrome	6.63e-05	0.000435	CcSEcCtD
Alfentanil—Dermatitis—Zonisamide—epilepsy syndrome	6.63e-05	0.000435	CcSEcCtD
Alfentanil—Dizziness—Oxcarbazepine—epilepsy syndrome	6.63e-05	0.000435	CcSEcCtD
Alfentanil—Nausea—Diazepam—epilepsy syndrome	6.6e-05	0.000433	CcSEcCtD
Alfentanil—Loss of consciousness—Gabapentin—epilepsy syndrome	6.59e-05	0.000432	CcSEcCtD
Alfentanil—Headache—Zonisamide—epilepsy syndrome	6.59e-05	0.000432	CcSEcCtD
Alfentanil—Angiopathy—Topiramate—epilepsy syndrome	6.58e-05	0.000431	CcSEcCtD
Alfentanil—Pruritus—Lamotrigine—epilepsy syndrome	6.57e-05	0.000431	CcSEcCtD
Alfentanil—Somnolence—Valproic Acid—epilepsy syndrome	6.56e-05	0.000431	CcSEcCtD
Alfentanil—Immune system disorder—Topiramate—epilepsy syndrome	6.55e-05	0.00043	CcSEcCtD
Alfentanil—Nervous system disorder—Pregabalin—epilepsy syndrome	6.55e-05	0.000429	CcSEcCtD
Alfentanil—Cough—Gabapentin—epilepsy syndrome	6.54e-05	0.000429	CcSEcCtD
Alfentanil—Mediastinal disorder—Topiramate—epilepsy syndrome	6.53e-05	0.000429	CcSEcCtD
Alfentanil—Tachycardia—Pregabalin—epilepsy syndrome	6.51e-05	0.000427	CcSEcCtD
Alfentanil—Chills—Topiramate—epilepsy syndrome	6.5e-05	0.000427	CcSEcCtD
Alfentanil—Convulsion—Gabapentin—epilepsy syndrome	6.5e-05	0.000426	CcSEcCtD
Alfentanil—Skin disorder—Pregabalin—epilepsy syndrome	6.48e-05	0.000425	CcSEcCtD
Alfentanil—Hypertension—Gabapentin—epilepsy syndrome	6.48e-05	0.000425	CcSEcCtD
Alfentanil—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.45e-05	0.000423	CcSEcCtD
Alfentanil—Vomiting—Clonazepam—epilepsy syndrome	6.45e-05	0.000423	CcSEcCtD
Alfentanil—Vomiting—Phenytoin—epilepsy syndrome	6.4e-05	0.00042	CcSEcCtD
Alfentanil—Rash—Clonazepam—epilepsy syndrome	6.39e-05	0.000419	CcSEcCtD
Alfentanil—Dermatitis—Clonazepam—epilepsy syndrome	6.39e-05	0.000419	CcSEcCtD
Alfentanil—Nausea—Felbamate—epilepsy syndrome	6.38e-05	0.000419	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	6.37e-05	0.000418	CcSEcCtD
Alfentanil—Vomiting—Oxcarbazepine—epilepsy syndrome	6.37e-05	0.000418	CcSEcCtD
Alfentanil—Fatigue—Valproic Acid—epilepsy syndrome	6.37e-05	0.000418	CcSEcCtD
Alfentanil—Dizziness—Carbamazepine—epilepsy syndrome	6.36e-05	0.000417	CcSEcCtD
Alfentanil—Headache—Clonazepam—epilepsy syndrome	6.35e-05	0.000417	CcSEcCtD
Alfentanil—Rash—Phenytoin—epilepsy syndrome	6.35e-05	0.000417	CcSEcCtD
Alfentanil—Mental disorder—Topiramate—epilepsy syndrome	6.35e-05	0.000417	CcSEcCtD
Alfentanil—Dermatitis—Phenytoin—epilepsy syndrome	6.34e-05	0.000416	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	6.34e-05	0.000416	CcSEcCtD
Alfentanil—Rash—Oxcarbazepine—epilepsy syndrome	6.32e-05	0.000414	CcSEcCtD
Alfentanil—Pain—Valproic Acid—epilepsy syndrome	6.31e-05	0.000414	CcSEcCtD
Alfentanil—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.31e-05	0.000414	CcSEcCtD
Alfentanil—Headache—Phenytoin—epilepsy syndrome	6.31e-05	0.000414	CcSEcCtD
Alfentanil—Erythema—Topiramate—epilepsy syndrome	6.31e-05	0.000414	CcSEcCtD
Alfentanil—Headache—Oxcarbazepine—epilepsy syndrome	6.28e-05	0.000412	CcSEcCtD
Alfentanil—Nausea—Zonisamide—epilepsy syndrome	6.25e-05	0.00041	CcSEcCtD
Alfentanil—Hypotension—Pregabalin—epilepsy syndrome	6.24e-05	0.000409	CcSEcCtD
Alfentanil—Confusional state—Gabapentin—epilepsy syndrome	6.17e-05	0.000405	CcSEcCtD
Alfentanil—Dizziness—Lamotrigine—epilepsy syndrome	6.14e-05	0.000403	CcSEcCtD
Alfentanil—Anaphylactic shock—Gabapentin—epilepsy syndrome	6.12e-05	0.000402	CcSEcCtD
Alfentanil—Vomiting—Carbamazepine—epilepsy syndrome	6.11e-05	0.000401	CcSEcCtD
Alfentanil—OPRM1—brain—epilepsy syndrome	6.11e-05	0.0246	CbGeAlD
Alfentanil—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.08e-05	0.000399	CcSEcCtD
Alfentanil—Rash—Carbamazepine—epilepsy syndrome	6.06e-05	0.000398	CcSEcCtD
Alfentanil—Dermatitis—Carbamazepine—epilepsy syndrome	6.06e-05	0.000397	CcSEcCtD
Alfentanil—Fentanyl—ABCB1—epilepsy syndrome	6.03e-05	0.0163	CrCbGaD
Alfentanil—Nausea—Clonazepam—epilepsy syndrome	6.02e-05	0.000395	CcSEcCtD
Alfentanil—Headache—Carbamazepine—epilepsy syndrome	6.02e-05	0.000395	CcSEcCtD
Alfentanil—Nervous system disorder—Gabapentin—epilepsy syndrome	6e-05	0.000394	CcSEcCtD
Alfentanil—Nausea—Phenytoin—epilepsy syndrome	5.98e-05	0.000392	CcSEcCtD
Alfentanil—Tachycardia—Gabapentin—epilepsy syndrome	5.97e-05	0.000392	CcSEcCtD
Alfentanil—Nausea—Oxcarbazepine—epilepsy syndrome	5.95e-05	0.00039	CcSEcCtD
Alfentanil—Vision blurred—Topiramate—epilepsy syndrome	5.95e-05	0.00039	CcSEcCtD
Alfentanil—Skin disorder—Gabapentin—epilepsy syndrome	5.95e-05	0.00039	CcSEcCtD
Alfentanil—Somnolence—Pregabalin—epilepsy syndrome	5.93e-05	0.000389	CcSEcCtD
Alfentanil—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.92e-05	0.000388	CcSEcCtD
Alfentanil—Vomiting—Lamotrigine—epilepsy syndrome	5.91e-05	0.000388	CcSEcCtD
Alfentanil—Urticaria—Valproic Acid—epilepsy syndrome	5.87e-05	0.000385	CcSEcCtD
Alfentanil—Rash—Lamotrigine—epilepsy syndrome	5.86e-05	0.000384	CcSEcCtD
Alfentanil—Dermatitis—Lamotrigine—epilepsy syndrome	5.85e-05	0.000384	CcSEcCtD
Alfentanil—Body temperature increased—Valproic Acid—epilepsy syndrome	5.84e-05	0.000383	CcSEcCtD
Alfentanil—Headache—Lamotrigine—epilepsy syndrome	5.82e-05	0.000382	CcSEcCtD
Alfentanil—Agitation—Topiramate—epilepsy syndrome	5.8e-05	0.00038	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.76e-05	0.000378	CcSEcCtD
Alfentanil—Fatigue—Pregabalin—epilepsy syndrome	5.76e-05	0.000378	CcSEcCtD
Alfentanil—Hypotension—Gabapentin—epilepsy syndrome	5.72e-05	0.000375	CcSEcCtD
Alfentanil—Nausea—Carbamazepine—epilepsy syndrome	5.71e-05	0.000375	CcSEcCtD
Alfentanil—Pain—Pregabalin—epilepsy syndrome	5.71e-05	0.000374	CcSEcCtD
Alfentanil—Loss of consciousness—Topiramate—epilepsy syndrome	5.55e-05	0.000364	CcSEcCtD
Alfentanil—Nausea—Lamotrigine—epilepsy syndrome	5.52e-05	0.000362	CcSEcCtD
Alfentanil—Cough—Topiramate—epilepsy syndrome	5.51e-05	0.000361	CcSEcCtD
Alfentanil—Feeling abnormal—Pregabalin—epilepsy syndrome	5.5e-05	0.000361	CcSEcCtD
Alfentanil—Convulsion—Topiramate—epilepsy syndrome	5.47e-05	0.000359	CcSEcCtD
Alfentanil—Hypertension—Topiramate—epilepsy syndrome	5.45e-05	0.000357	CcSEcCtD
Alfentanil—Somnolence—Gabapentin—epilepsy syndrome	5.44e-05	0.000357	CcSEcCtD
Alfentanil—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.44e-05	0.000357	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.33e-05	0.00035	CcSEcCtD
Alfentanil—Urticaria—Pregabalin—epilepsy syndrome	5.3e-05	0.000348	CcSEcCtD
Alfentanil—Asthenia—Valproic Acid—epilepsy syndrome	5.3e-05	0.000348	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.28e-05	0.000347	CcSEcCtD
Alfentanil—Fatigue—Gabapentin—epilepsy syndrome	5.28e-05	0.000346	CcSEcCtD
Alfentanil—Body temperature increased—Pregabalin—epilepsy syndrome	5.28e-05	0.000346	CcSEcCtD
Alfentanil—Pain—Gabapentin—epilepsy syndrome	5.23e-05	0.000343	CcSEcCtD
Alfentanil—ALB—brain—epilepsy syndrome	5.23e-05	0.0211	CbGeAlD
Alfentanil—Pruritus—Valproic Acid—epilepsy syndrome	5.22e-05	0.000343	CcSEcCtD
Alfentanil—Confusional state—Topiramate—epilepsy syndrome	5.19e-05	0.000341	CcSEcCtD
Alfentanil—Nervous system disorder—Topiramate—epilepsy syndrome	5.05e-05	0.000331	CcSEcCtD
Alfentanil—Feeling abnormal—Gabapentin—epilepsy syndrome	5.04e-05	0.000331	CcSEcCtD
Alfentanil—Tachycardia—Topiramate—epilepsy syndrome	5.03e-05	0.00033	CcSEcCtD
Alfentanil—Skin disorder—Topiramate—epilepsy syndrome	5e-05	0.000328	CcSEcCtD
Alfentanil—Hyperhidrosis—Topiramate—epilepsy syndrome	4.98e-05	0.000327	CcSEcCtD
Alfentanil—Hypersensitivity—Pregabalin—epilepsy syndrome	4.92e-05	0.000323	CcSEcCtD
Alfentanil—Dizziness—Valproic Acid—epilepsy syndrome	4.88e-05	0.00032	CcSEcCtD
Alfentanil—Urticaria—Gabapentin—epilepsy syndrome	4.86e-05	0.000319	CcSEcCtD
Alfentanil—Body temperature increased—Gabapentin—epilepsy syndrome	4.84e-05	0.000317	CcSEcCtD
Alfentanil—Hypotension—Topiramate—epilepsy syndrome	4.81e-05	0.000316	CcSEcCtD
Alfentanil—Asthenia—Pregabalin—epilepsy syndrome	4.79e-05	0.000314	CcSEcCtD
Alfentanil—Pruritus—Pregabalin—epilepsy syndrome	4.72e-05	0.00031	CcSEcCtD
Alfentanil—Vomiting—Valproic Acid—epilepsy syndrome	4.69e-05	0.000308	CcSEcCtD
Alfentanil—Rash—Valproic Acid—epilepsy syndrome	4.66e-05	0.000305	CcSEcCtD
Alfentanil—Dermatitis—Valproic Acid—epilepsy syndrome	4.65e-05	0.000305	CcSEcCtD
Alfentanil—Headache—Valproic Acid—epilepsy syndrome	4.63e-05	0.000303	CcSEcCtD
Alfentanil—Somnolence—Topiramate—epilepsy syndrome	4.58e-05	0.0003	CcSEcCtD
Alfentanil—Hypersensitivity—Gabapentin—epilepsy syndrome	4.51e-05	0.000296	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.45e-05	0.000292	CcSEcCtD
Alfentanil—Fatigue—Topiramate—epilepsy syndrome	4.44e-05	0.000291	CcSEcCtD
Alfentanil—Dizziness—Pregabalin—epilepsy syndrome	4.41e-05	0.00029	CcSEcCtD
Alfentanil—Pain—Topiramate—epilepsy syndrome	4.4e-05	0.000289	CcSEcCtD
Alfentanil—Asthenia—Gabapentin—epilepsy syndrome	4.39e-05	0.000288	CcSEcCtD
Alfentanil—Nausea—Valproic Acid—epilepsy syndrome	4.39e-05	0.000288	CcSEcCtD
Alfentanil—Pruritus—Gabapentin—epilepsy syndrome	4.33e-05	0.000284	CcSEcCtD
Alfentanil—ABCB1—forebrain—epilepsy syndrome	4.24e-05	0.0171	CbGeAlD
Alfentanil—Vomiting—Pregabalin—epilepsy syndrome	4.24e-05	0.000278	CcSEcCtD
Alfentanil—Feeling abnormal—Topiramate—epilepsy syndrome	4.24e-05	0.000278	CcSEcCtD
Alfentanil—Rash—Pregabalin—epilepsy syndrome	4.21e-05	0.000276	CcSEcCtD
Alfentanil—Dermatitis—Pregabalin—epilepsy syndrome	4.21e-05	0.000276	CcSEcCtD
Alfentanil—Headache—Pregabalin—epilepsy syndrome	4.18e-05	0.000274	CcSEcCtD
Alfentanil—Urticaria—Topiramate—epilepsy syndrome	4.09e-05	0.000268	CcSEcCtD
Alfentanil—Body temperature increased—Topiramate—epilepsy syndrome	4.07e-05	0.000267	CcSEcCtD
Alfentanil—Dizziness—Gabapentin—epilepsy syndrome	4.05e-05	0.000266	CcSEcCtD
Alfentanil—Nausea—Pregabalin—epilepsy syndrome	3.97e-05	0.00026	CcSEcCtD
Alfentanil—ABCB1—telencephalon—epilepsy syndrome	3.9e-05	0.0157	CbGeAlD
Alfentanil—Vomiting—Gabapentin—epilepsy syndrome	3.89e-05	0.000255	CcSEcCtD
Alfentanil—Rash—Gabapentin—epilepsy syndrome	3.86e-05	0.000253	CcSEcCtD
Alfentanil—Dermatitis—Gabapentin—epilepsy syndrome	3.86e-05	0.000253	CcSEcCtD
Alfentanil—Headache—Gabapentin—epilepsy syndrome	3.83e-05	0.000252	CcSEcCtD
Alfentanil—Hypersensitivity—Topiramate—epilepsy syndrome	3.79e-05	0.000249	CcSEcCtD
Alfentanil—Asthenia—Topiramate—epilepsy syndrome	3.69e-05	0.000242	CcSEcCtD
Alfentanil—Pruritus—Topiramate—epilepsy syndrome	3.64e-05	0.000239	CcSEcCtD
Alfentanil—Nausea—Gabapentin—epilepsy syndrome	3.64e-05	0.000239	CcSEcCtD
Alfentanil—Dizziness—Topiramate—epilepsy syndrome	3.41e-05	0.000223	CcSEcCtD
Alfentanil—Vomiting—Topiramate—epilepsy syndrome	3.27e-05	0.000215	CcSEcCtD
Alfentanil—CYP3A4—nervous system—epilepsy syndrome	3.26e-05	0.0131	CbGeAlD
Alfentanil—Rash—Topiramate—epilepsy syndrome	3.25e-05	0.000213	CcSEcCtD
Alfentanil—Dermatitis—Topiramate—epilepsy syndrome	3.24e-05	0.000213	CcSEcCtD
Alfentanil—Headache—Topiramate—epilepsy syndrome	3.23e-05	0.000212	CcSEcCtD
Alfentanil—CYP3A4—central nervous system—epilepsy syndrome	3.13e-05	0.0126	CbGeAlD
Alfentanil—ABCB1—medulla oblongata—epilepsy syndrome	3.07e-05	0.0124	CbGeAlD
Alfentanil—Nausea—Topiramate—epilepsy syndrome	3.06e-05	0.000201	CcSEcCtD
Alfentanil—ABCB1—midbrain—epilepsy syndrome	2.8e-05	0.0113	CbGeAlD
Alfentanil—ABCB1—spinal cord—epilepsy syndrome	2.73e-05	0.011	CbGeAlD
Alfentanil—ABCB1—head—epilepsy syndrome	2.43e-05	0.00979	CbGeAlD
Alfentanil—ABCB1—nervous system—epilepsy syndrome	2.3e-05	0.00928	CbGeAlD
Alfentanil—ABCB1—central nervous system—epilepsy syndrome	2.22e-05	0.00894	CbGeAlD
Alfentanil—ABCB1—cerebellum—epilepsy syndrome	2.17e-05	0.00874	CbGeAlD
Alfentanil—ABCB1—brain—epilepsy syndrome	1.76e-05	0.0071	CbGeAlD
Alfentanil—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	8.86e-06	0.000226	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PDXK—epilepsy syndrome	8.86e-06	0.000226	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—FAR1—epilepsy syndrome	8.86e-06	0.000226	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ST3GAL3—epilepsy syndrome	8.8e-06	0.000225	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AQP1—epilepsy syndrome	8.75e-06	0.000223	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ASAH1—epilepsy syndrome	8.71e-06	0.000222	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP2C19—epilepsy syndrome	8.69e-06	0.000222	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCR3—epilepsy syndrome	8.67e-06	0.000221	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	8.67e-06	0.000221	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP11A1—epilepsy syndrome	8.64e-06	0.000221	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ADSL—epilepsy syndrome	8.62e-06	0.00022	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	8.61e-06	0.00022	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—STXBP1—epilepsy syndrome	8.47e-06	0.000216	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	8.45e-06	0.000216	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NPY—epilepsy syndrome	8.45e-06	0.000216	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GLUL—epilepsy syndrome	8.45e-06	0.000216	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	8.3e-06	0.000212	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CACNA1D—epilepsy syndrome	8.3e-06	0.000212	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NT5E—epilepsy syndrome	8.26e-06	0.000211	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALAD—epilepsy syndrome	8.26e-06	0.000211	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—AGT—epilepsy syndrome	8.23e-06	0.00021	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	8.21e-06	0.00021	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—OXT—epilepsy syndrome	8.15e-06	0.000208	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HSPB1—epilepsy syndrome	8.15e-06	0.000208	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCL3—epilepsy syndrome	8.15e-06	0.000208	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CRH—epilepsy syndrome	8.15e-06	0.000208	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CXCL2—epilepsy syndrome	8.15e-06	0.000208	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—FYN—epilepsy syndrome	8.12e-06	0.000207	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	8.1e-06	0.000207	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PNPO—epilepsy syndrome	8.1e-06	0.000207	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	8.1e-06	0.000207	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GAMT—epilepsy syndrome	8.1e-06	0.000207	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	8.06e-06	0.000206	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CCR5—epilepsy syndrome	8.04e-06	0.000205	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	7.91e-06	0.000202	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	7.91e-06	0.000202	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	7.88e-06	0.000201	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	7.88e-06	0.000201	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	7.87e-06	0.000201	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—YWHAZ—epilepsy syndrome	7.8e-06	0.000199	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP2D6—epilepsy syndrome	7.8e-06	0.000199	CbGpPWpGaD
Alfentanil—ALB—Metabolism—TXNRD1—epilepsy syndrome	7.76e-06	0.000198	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	7.71e-06	0.000197	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	7.71e-06	0.000197	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	7.64e-06	0.000195	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.6e-06	0.000194	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TSC1—epilepsy syndrome	7.58e-06	0.000193	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PTK2B—epilepsy syndrome	7.58e-06	0.000193	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ADSL—epilepsy syndrome	7.55e-06	0.000193	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AQP1—epilepsy syndrome	7.53e-06	0.000192	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—QDPR—epilepsy syndrome	7.53e-06	0.000192	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CA4—epilepsy syndrome	7.53e-06	0.000192	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	7.51e-06	0.000192	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—AGT—epilepsy syndrome	7.47e-06	0.000191	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ADRA2A—epilepsy syndrome	7.42e-06	0.000189	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GLUL—epilepsy syndrome	7.41e-06	0.000189	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	7.4e-06	0.000189	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—BCHE—epilepsy syndrome	7.39e-06	0.000189	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SST—epilepsy syndrome	7.37e-06	0.000188	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NTRK2—epilepsy syndrome	7.37e-06	0.000188	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCR2—epilepsy syndrome	7.37e-06	0.000188	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	7.34e-06	0.000187	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—DUSP6—epilepsy syndrome	7.31e-06	0.000187	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	7.27e-06	0.000186	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.24e-06	0.000185	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	7.23e-06	0.000184	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	7.22e-06	0.000184	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PLAT—epilepsy syndrome	7.19e-06	0.000183	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	7.15e-06	0.000182	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—COX3—epilepsy syndrome	7.08e-06	0.000181	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	7.05e-06	0.00018	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	7.04e-06	0.00018	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	6.98e-06	0.000178	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—TH—epilepsy syndrome	6.95e-06	0.000177	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CXCL12—epilepsy syndrome	6.93e-06	0.000177	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	6.93e-06	0.000177	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PLAU—epilepsy syndrome	6.93e-06	0.000177	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—POMC—epilepsy syndrome	6.92e-06	0.000177	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	6.9e-06	0.000176	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	6.87e-06	0.000175	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CHRM3—epilepsy syndrome	6.81e-06	0.000174	CbGpPWpGaD
Alfentanil—ALB—Metabolism—KCNJ11—epilepsy syndrome	6.81e-06	0.000174	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CNR1—epilepsy syndrome	6.81e-06	0.000174	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—JUNB—epilepsy syndrome	6.81e-06	0.000174	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	6.8e-06	0.000174	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PLCB1—epilepsy syndrome	6.78e-06	0.000173	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.76e-06	0.000172	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.71e-06	0.000171	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.71e-06	0.000171	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.71e-06	0.000171	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.71e-06	0.000171	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.71e-06	0.000171	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.69e-06	0.000171	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HTR7—epilepsy syndrome	6.64e-06	0.000169	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AQP1—epilepsy syndrome	6.6e-06	0.000168	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	6.45e-06	0.000165	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HBEGF—epilepsy syndrome	6.45e-06	0.000165	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PRKCB—epilepsy syndrome	6.44e-06	0.000164	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NOS2—epilepsy syndrome	6.36e-06	0.000162	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.34e-06	0.000162	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKT3—epilepsy syndrome	6.33e-06	0.000161	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—POMC—epilepsy syndrome	6.29e-06	0.00016	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	6.28e-06	0.00016	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	6.25e-06	0.000159	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.22e-06	0.000159	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ADAM10—epilepsy syndrome	6.18e-06	0.000158	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CCL2—epilepsy syndrome	6.15e-06	0.000157	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NEU1—epilepsy syndrome	6.14e-06	0.000157	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—UPB1—epilepsy syndrome	6.14e-06	0.000157	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ATIC—epilepsy syndrome	6.14e-06	0.000157	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	6.03e-06	0.000154	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	5.97e-06	0.000152	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CHRM3—epilepsy syndrome	5.97e-06	0.000152	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.91e-06	0.000151	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—S100B—epilepsy syndrome	5.84e-06	0.000149	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	5.8e-06	0.000148	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SOCS3—epilepsy syndrome	5.79e-06	0.000148	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDC42—epilepsy syndrome	5.77e-06	0.000147	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CAT—epilepsy syndrome	5.72e-06	0.000146	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.71e-06	0.000146	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.71e-06	0.000146	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	5.64e-06	0.000144	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AVP—epilepsy syndrome	5.59e-06	0.000143	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	5.57e-06	0.000142	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ABCG2—epilepsy syndrome	5.55e-06	0.000142	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP2C19—epilepsy syndrome	5.41e-06	0.000138	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP11A1—epilepsy syndrome	5.38e-06	0.000137	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.37e-06	0.000137	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	5.37e-06	0.000137	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—BCHE—epilepsy syndrome	5.34e-06	0.000136	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.34e-06	0.000136	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HES1—epilepsy syndrome	5.29e-06	0.000135	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.22e-06	0.000133	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GPX1—epilepsy syndrome	5.18e-06	0.000132	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	5.14e-06	0.000131	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	5.12e-06	0.000131	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	5.11e-06	0.00013	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	5.1e-06	0.00013	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.09e-06	0.00013	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.09e-06	0.00013	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	5.04e-06	0.000129	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—TH—epilepsy syndrome	5.02e-06	0.000128	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	4.94e-06	0.000126	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	4.89e-06	0.000125	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ABCG2—epilepsy syndrome	4.87e-06	0.000124	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP2D6—epilepsy syndrome	4.85e-06	0.000124	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.85e-06	0.000124	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.85e-06	0.000124	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	4.75e-06	0.000121	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.75e-06	0.000121	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	4.74e-06	0.000121	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	4.71e-06	0.00012	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.65e-06	0.000119	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	4.65e-06	0.000119	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ADRA2A—epilepsy syndrome	4.62e-06	0.000118	CbGpPWpGaD
Alfentanil—ALB—Metabolism—BCHE—epilepsy syndrome	4.6e-06	0.000117	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.56e-06	0.000116	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	4.56e-06	0.000116	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AGT—epilepsy syndrome	4.54e-06	0.000116	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.49e-06	0.000115	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.48e-06	0.000114	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—APOE—epilepsy syndrome	4.45e-06	0.000113	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	4.42e-06	0.000113	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	4.41e-06	0.000113	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SLC2A1—epilepsy syndrome	4.39e-06	0.000112	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PLCB1—epilepsy syndrome	4.34e-06	0.000111	CbGpPWpGaD
Alfentanil—ALB—Metabolism—TH—epilepsy syndrome	4.33e-06	0.00011	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	4.32e-06	0.00011	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.26e-06	0.000109	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	4.25e-06	0.000109	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	4.24e-06	0.000108	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	4.19e-06	0.000107	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.19e-06	0.000107	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CAT—epilepsy syndrome	4.14e-06	0.000106	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	4.08e-06	0.000104	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.07e-06	0.000104	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	4.06e-06	0.000104	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.06e-06	0.000104	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	4.05e-06	0.000103	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—BCHE—epilepsy syndrome	4.03e-06	0.000103	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	4.02e-06	0.000103	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	3.85e-06	9.82e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—POMC—epilepsy syndrome	3.82e-06	9.75e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PLCB1—epilepsy syndrome	3.8e-06	9.71e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—TH—epilepsy syndrome	3.79e-06	9.68e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—SRC—epilepsy syndrome	3.78e-06	9.66e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GPX1—epilepsy syndrome	3.74e-06	9.55e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	3.71e-06	9.48e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—VEGFA—epilepsy syndrome	3.69e-06	9.41e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.68e-06	9.39e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.68e-06	9.39e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	3.63e-06	9.27e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—HMOX1—epilepsy syndrome	3.61e-06	9.22e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CAT—epilepsy syndrome	3.56e-06	9.09e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALB—epilepsy syndrome	3.48e-06	8.89e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ABCB1—epilepsy syndrome	3.47e-06	8.85e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	3.28e-06	8.38e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AGT—epilepsy syndrome	3.28e-06	8.37e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GPX1—epilepsy syndrome	3.22e-06	8.22e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APOE—epilepsy syndrome	3.21e-06	8.2e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HMOX1—epilepsy syndrome	3.16e-06	8.08e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CAT—epilepsy syndrome	3.12e-06	7.97e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	3.05e-06	7.78e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	3.05e-06	7.78e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3e-06	7.65e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	2.99e-06	7.63e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.92e-06	7.46e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.9e-06	7.41e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AGT—epilepsy syndrome	2.83e-06	7.21e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.82e-06	7.21e-05	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.78e-06	7.08e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOE—epilepsy syndrome	2.77e-06	7.07e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—POMC—epilepsy syndrome	2.76e-06	7.05e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	2.75e-06	7.02e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	2.67e-06	6.82e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.62e-06	6.69e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	2.6e-06	6.63e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	2.52e-06	6.43e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALB—epilepsy syndrome	2.52e-06	6.43e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.49e-06	6.37e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.48e-06	6.34e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AGT—epilepsy syndrome	2.48e-06	6.32e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOE—epilepsy syndrome	2.43e-06	6.19e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	2.4e-06	6.11e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—POMC—epilepsy syndrome	2.38e-06	6.07e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.37e-06	6.05e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—AKT1—epilepsy syndrome	2.35e-06	6e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.34e-06	5.98e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—TH—epilepsy syndrome	2.34e-06	5.96e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	2.33e-06	5.96e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	2.2e-06	5.62e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—POMC—epilepsy syndrome	2.08e-06	5.32e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.95e-06	4.98e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.92e-06	4.91e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALB—epilepsy syndrome	1.9e-06	4.85e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTGS2—epilepsy syndrome	1.9e-06	4.84e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.87e-06	4.78e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.74e-06	4.44e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.66e-06	4.24e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AKT1—epilepsy syndrome	1.53e-06	3.91e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.53e-06	3.89e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.49e-06	3.81e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.49e-06	3.8e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.28e-06	3.28e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.17e-06	2.99e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AKT1—epilepsy syndrome	1.11e-06	2.83e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.02e-06	2.61e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AKT1—epilepsy syndrome	9.53e-07	2.43e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AKT1—epilepsy syndrome	8.35e-07	2.13e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.15e-07	1.31e-05	CbGpPWpGaD
